Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | JNK-IN-11 | 0.3 | uM | 3 | M-CSF | 132.0 | 81 | ||||
N2586 | EGF | 100 | ng/mL | 3 | M-CSF | 183.0 | 82 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | M-CSF | 173.5 | 64 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | M-CSF | 172.5 | 60 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | M-CSF | 238.0 | 65 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | M-CSF | 181.0 | 62 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | M-CSF | 144.0 | 67 | |
N2586 | JNK-IN-11 | 0.3 | uM | 3 | M-CSF | 89.0 | 61 | ||||
RA2159 | 3 | M-CSF | 99.0 | 81 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | M-CSF | 85.0 | 55 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | M-CSF | 83.0 | 59 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | M-CSF | 120.5 | 66 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 127.0 | 51 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | M-CSF | 119.0 | 54 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 3 | M-CSF | 104.5 | 88 | ||||
N2586 | 3 | M-CSF | 156.0 | 83 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | M-CSF | 186.0 | 62 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | M-CSF | 127.5 | 58 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | M-CSF | 319.0 | 57 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 204.0 | 63 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | M-CSF | 116.5 | 60 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 3 | M-CSF | 131.0 | 52 | ||||
RA2159 | IL-17A | 100 | ng/mL | 3 | M-CSF | 118.0 | 69 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | M-CSF | 102.5 | 68 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | M-CSF | 119.0 | 68 |